Research into cancer’s causes, cures, prevention, and care processes (patient experiences) remains a hallmark of complete cancer programs. While most programs struggle to meet ACoS requirements to enroll a minimum of 2% of their adult patients onto clinical trials, a number of community cancer programs exceed that rate, reaching adult enrollment of 10%+ their analytic cancer patient volume.
The Oncology Group can assist your team to expand its clinical trials programs, including broadening the physician base of those who place patients on trials, improving the enrollment process (including patient consent and IRB oversight),as well as expanding the number and variety of trials open or accessible from your institution.